LNSR
LENSAR Inc
NASDAQ: LNSR · HEALTHCARE · MEDICAL DEVICES
$5.92
-0.34% today
Updated 2026-10-28
Market cap
$74.58M
P/E ratio
33.72
P/S ratio
1.24x
EPS (TTM)
$0.18
Dividend yield
—
52W range
$5 – $13
Volume
0.1M
LENSAR Inc (LNSR) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$5.92
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$6.68
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.1B | $0.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: 57.60%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.